China Ophthalmic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Chinese Ophthalmic Devices Market is segmented by Device (Surgical Devices (Glaucoma Devices, Intraocular Lenses, Lasers, Other Surgical Device), Diagnostic Devices, and Monitoring Devices (Autorefractors and Keratometers, Ophthalmic Ultrasound Imaging Systems, Ophthalmoscopes, Optical Coherence Tomography Scanners, Other Diagnostic and Monitoring Devices). The report offers the value (in USD million) for the above segments.

Market Snapshot

CAGR
Study Period: 2019-2027
Base Year: 2021
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Chinese ophthalmic devices market is expected to register a CAGR of 4.5% during the forecast period.

The COVID-19 pandemic had interrupted the healthcare services provided all over the nation. Most of the general medical services that were not urgent were postponed to preventing the further spread of the pandemic. Several ophthalmologic surgeries, which were deemed not urgent, were also postponed. According to the study published in April 2020, titled "A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology" Ophthalmologists were at high risk of getting severe acute respiratory syndrome coronavirus 2 due to face-to-face dialogue with patients, frequent exposure to tears, and ocular discharge, and the inevitable use of equipment that demands closed closeness (sars-cov-2). As a result, patient visits to the ophthalmology department had decreased. Thus, the decline in the patient visits, as well as the lack of the supply chain of medical devices in the country, has hampered the market growth. Furthermore, once patient visits resume and COVID-19 instances decline, the market is expected to return to pre-pandemic levels in the near future.

Certain factors that are driving the growth of the market include demographic shift, the impact of the prevalence of eye disease, technological advancements in the field of ophthalmology, and the rising geriatric population. The article “Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study” published in March 2022 highlighted that myopia leads to a substantial economic burden in China due to which China contributes to a significant proportion of myopia in the world. Ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices have gained increasing importance and adoption due to the increasing prevalence of various eye diseases, such as glaucoma, cataract, and other vision-related issues. The rising prevalence of eye-related diseases is leading to an increased demand for ophthalmic devices.

The various strategies adopted by the key market players such as product launch mergers and acquisitions and fundraising expand the market in the nations. For instance, in May 2022, Suzhou Micro clear Medical recently closed a CNY tens million Series C investment transaction. Dyee Capital was the sole investor in this round of funding. The funds will be used to further R&D and promote sales of its ultra-wide-angle laser color ophthalmic imaging systems. Thus, all the above-mentioned factors are expected to boost market growth over the forecast period. However, the risk associated with ophthalmic procedures may restrain the market growth over the forecast period.

Scope of the report

As per the scope of the report, ophthalmology is a branch of medical sciences that deals with the structure, function, and various diseases related to the eye. Ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. The Chinese Ophthalmic Devices Market is segmented by Device (Surgical Devices (Glaucoma Devices, Intraocular Lenses, Lasers, Other Surgical Device), Diagnostic Devices, and Monitoring Devices (Autorefractors and Keratometers, Ophthalmic Ultrasound Imaging Systems, Ophthalmoscopes, Optical Coherence Tomography Scanners, Other Diagnostic and Monitoring Devices). The report offers the value (in USD million) for the above segments.

By Devices
Surgical Devices
Glaucoma Devices
Intraocular Lenses
Lasers
Other Surgical Devices
Diagnostic and Monitoring Devices
Autorefractors and Keratometers
Ophthalmic Ultrasound Imaging Systems
Ophthalmoscopes
Optical Coherence Tomography Scanners
Other Diagnostic and Monitoring Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

Glaucoma Devices Segment is Expected to Show Better Growth over the Forecast Period

Glaucoma devices include glaucoma drainage devices and glaucoma implants, stents, lenses, and others. The segment is driven by the rising prevalence of glaucoma and product launches by the key market players.

According to the study titled “Knowledge of glaucoma and associated factors among primary glaucoma patients in Kunming, China” published in February 2022, China is the world's most populous country, and has the highest rate of glaucoma. In addition, as per the source mentioned above, in 2020, China had 15.58 million people with all types of glaucoma, and by 2050, China will have 25.16 million people with all types of glaucoma. Glaucoma prevalence reached 1.05 % in 2020 and is expected to rise to 1.33 % in 2050. As a result of the rising prevalence of eye diseases, the contact lens segment is expected to witness increased demand.

Additionally, the launch of new products in the market is also contributing to the growth of the market segment. For instance, in April 2020, Allergan plc disclosed The National Medical Products Administration (NMPA) of China has accepted the registration of Allergan's XEN Gel Stent for the surgical therapy of refractory glaucoma patients. XEN is the first product in China to be approved via the Real-World Evidence method. Additionally, in July 2021, the Paul Glaucoma Implant (PGI), Advanced Ophthalmic Innovations' next-generation glaucoma implant, was successfully implanted for the first time in China at Boao Super Hospital in Hainan. These initiatives are accelerating the market's expansion. Thus, the above-mentioned factors are expected to increase the market growth.

China Ophthalmic Devices Market 1

Competitive Landscape

The China Ophthalmic Devices Market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market The global players in the Chinese ophthalmic devices market are Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Hoya Corporation, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, and Ziemer Group AG.

Major Players

  1. Alcon Inc.

  2. Bausch Health Companies Inc.

  3. Ziemer Group AG

  4. Carl Zeiss Meditec AG

  5. Johnson & Johnson

Picture1.png

Recent Development

  • In June 2022, Samsara Vision has teamed up with Lansheng Medical "MyVision," a China-based ophthalmology company, to create a comprehensive clinical and commercial organisation to support Samsara Vision's SING IMTTM (Smaller-Incision New-Generation Implantable Miniature Telescope) in mainland China, Macau, the Hanain Province, and Hong Kong.
  • In June 2022, the National Medical Products Administration in China has granted Iridex Corporation permission to market and sell its Cyclo G6 platform for the treatment of glaucoma illnesses (NMPA). According to the clearance, Iridex and distribution partners Topcon and Clinico will begin selling the Cyclo G6 system and accompanying probes in China in the third quarter of 2022.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Eye Diseases

      2. 4.2.2 Technological Advancements in Ophthalmic Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Risk Associated with Ophthalmic Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Devices

      1. 5.1.1 Surgical Devices

        1. 5.1.1.1 Glaucoma Devices

        2. 5.1.1.2 Intraocular Lenses

        3. 5.1.1.3 Lasers

        4. 5.1.1.4 Other Surgical Devices

      2. 5.1.2 Diagnostic and Monitoring Devices

        1. 5.1.2.1 Autorefractors and Keratometers

        2. 5.1.2.2 Ophthalmic Ultrasound Imaging Systems

        3. 5.1.2.3 Ophthalmoscopes

        4. 5.1.2.4 Optical Coherence Tomography Scanners

        5. 5.1.2.5 Other Diagnostic and Monitoring Devices

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alcon Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 Hoya Corporation

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Nidek Co. Ltd

      7. 6.1.7 Topcon Corporation

      8. 6.1.8 Ziemer Group AG

      9. 6.1.9 Quantel Medical

      10. 6.1.10 Lumenis

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The China Ophthalmic Devices Market market is studied from 2019 - 2027.

The China Ophthalmic Devices Market is growing at a CAGR of 4.5% over the next 5 years.

Alcon Inc., Bausch Health Companies Inc., Ziemer Group AG, Carl Zeiss Meditec AG, Johnson & Johnson are the major companies operating in China Ophthalmic Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!